Created in 2015 (Japan), RXULTI brexpiprazole own 146 sister brands and 17477 competing brands. RXULTI brexpiprazole's notoriety arose from exemplary management which optimizes product quality and client satisfaction, which in turn generate financial performance, and therefore, stock performance. Being a Popular brand online is assessed based on the evolution of worldwide Web searches over the last five years.

RXULTI brexpiprazole is a brand of OTSUKA HOLDING CO LTD (OS1) Popularity

Buy OTSUKA HOLDING CO LTD share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
The following interest graph for RXULTI brexpiprazole shows the evolution of worldwide Web searches in the last five years. The graph shows the evolution of RXULTI brexpiprazole search rates over time, with a value of 100 indicating the month when it was highest.
Compare the 5-year Web notoriety graph with the 5-year market price graph:
Notoriety -> Market prices